{
    "nctId": "NCT01984866",
    "briefTitle": "CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.",
    "officialTitle": "Complete Pathological Response Prediction After Neoadjuvant Treatment Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.",
    "overallStatus": "TERMINATED",
    "conditions": "Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 13,
    "primaryOutcomeMeasure": "determination of the negative predictive value (NPV) of the excisional biopsy technique",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Informed consent Form signed\n* Adequate Performance status (ECOG 0-1)\n* Female patients with unifocal breast tumors (stages II-III, TN, HER2+ or Luminal B) very sensitive to neoadjuvant medical treatment (5 to 6 months in accordance with the current standard)\n* Patients who submit clinical-radiologic greater response to the treatment administered (equal to or less than 1.5 cm in NMR residual tumor)\n\nExclusion Criteria:\n\n* Ki67\\<14%\n* Excisional biopsy Contraindications",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}